Price
No data yet.
Social Signal Score
Analyst Ratings
18 analystsRevenue
$367.67M+34.04%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Christopher J. Bilotto
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Employees
- 600
- Beta
- 2.29
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -0.20
Financials
Revenue
$367.67M+34.0%Net Income
$-50.23M-217.1%EBITDA
$47.81M-70.1%Free Cash Flow
$521.0K-97.8%EPS (diluted)
$-0.21-216.7%Shares Outstanding (diluted)
240.98M+1.5%Operating Expenses
$14.64MCash & Debt
$110.66MReturn of Capital
$4.98MRevenue by Segment (annual)
$1.54BDividend per Share
$0.01Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.54B | $-285.89M | $-1.19 |
| 2024 | $1.50B | $-370.25M | $-1.55 |
| 2023 | $1.41B | $-293.57M | $-1.23 |
| 2022 | $1.28B | $-15.77M | $-0.07 |
| 2021 | $1.38B | $174.51M | $0.73 |
| 2020 | $1.63B | $-139.45M | $-0.59 |
| 2019 | $1.04B | $-88.23M | $-0.37 |
| 2018 | $1.12B | $286.87M | $1.21 |
| 2017 | $1.07B | $147.61M | $0.62 |
| 2016 | $1.06B | $141.29M | $0.60 |
| 2015 | $998.77M | $123.97M | $0.54 |
| 2014 | $844.89M | $158.64M | $0.81 |
| 2013 | $761.44M | $151.16M | $0.98 |
| 2012 | $634.80M | $131.82M | $0.78 |
Valuation
DHChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
25-82.14%Social Signal Score
Mentions (6)
- Newsseekingalpha.com·12d ago·Negative
5 REITs I Would Never Buy, No Matter How Cheap Poor management can destroy value, even with great assets. RMR-managed REITs have consistently underperformed. Excessive debt and dilution hurt shareholders.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Diversified Healthcare Trust (DHC) Q3 2026 Earnings Call Transcript Diversified Healthcare Trust ( DHC ) Q3 2026 Earnings Call November 3, 2026 10:00 AM EST Company Participants Matt Murphy - Manager of Investor Relations Christopher Bilotto - President, CEO & Managing Trustee Matthew Brown - CFO & Treasurer Conference Call Participants Henry Newell - RBC Capital Markets, Research Division John Massocca - B. Riley Securities, Inc., Research Division Presentation Operator Good morning, and welcom…
View source ↗ - Newsmarketbeat.com·19d ago·Negative
Diversified Healthcare Trust Q3 Earnings Call Highlights Diversified Healthcare Trust NASDAQ: DHC reported third-quarter results marked by continued growth in its senior housing operating portfolio, higher same-property net operating income and reduced capital expenditure expectations, while updating the presentation of certain non-GAAP measures to include accrued incentive management fees.
View source ↗ - Newszacks.com·20d ago·Negative
Diversified Healthcare (DHC) Q3 FFO and Revenues Lag Estimates Diversified Healthcare (DHC) came out with quarterly funds from operations (FFO) of $0.13 per share, missing the Zacks Consensus Estimate of $0.15 per share. This compares to FFO of $0.04 per share a year ago.
View source ↗ - Newsbusinesswire.com·20d ago·Neutral
Diversified Healthcare Trust Announces Third Quarter 2026 Results NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) today announced its financial results for the quarter ended September 30, 2026, and provided updated full year 2026 financial guidance, which can be found at the Quarterly Reports section of DHC's website at https://www.dhcreit.com/investors/financial-information/quarterly/default.aspx. A conference call to discuss DHC's third quarter 2026 financial results…
View source ↗ - Newsseekingalpha.com·92d ago·Positive
Diversified Healthcare Trust: A Cautious Buy Diversified Healthcare Trust is rated 'Buy' as fundamentals and balance sheet have improved despite recent share price gains. Q2 2026 saw SHOP NOI up 37.2% YoY and margin expansion, with normalized FFO surging 109.4% to $0.16/share. DHC's deleveraging is notable: net debt to adjusted EBITDAre fell to 7.1x, with no major maturities until 2028 and $270M in liquidity.
View source ↗
Earnings
Mon, Feb 22(in 3 months)
Consensus estimate $-0.14 per share
Typical surprise +118.6% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 2$-0.21 vs $-0.15miss
- Mon, Aug 3$-0.16 vs $-0.15miss
- Mon, May 4$-0.18 vs $-0.16miss
- Mon, Feb 23$0.09 vs $-0.17beat
- Mon, Nov 3$0.04 vs $-0.21beat
- Mon, Aug 4$0.08 vs $-0.22beat
Estimates and results for DHC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DHC officers and directors.
- Bought
- $46.8m
- Sold
- $174k
12 trades
2 trades
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
- Portnoy Adam D.bought
86 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in DHC.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
